Oncology-focused digital therapeutics company Mika Health and global non-profit Cancer Support Community (CSC) announced the pair will provide an AI-enabled oncology-focused digital therapeutic for U.S.-based cancer patients and their caregivers to access mental health…
Continue Reading
By 2030, the healthcare artificial intelligence market is expected to be worth almost $188 billion.The Institute of Electrical and Electronic Engineers, the world’s largest nonprofit technical organization dedicated to the advancement of technology for…
Continue Reading
Background: Unaddressed early-stage mental health issues, including stress, anxiety, and mild depression, can become a burden for individuals in the long term. Digital phenotyping involves capturing continuous behavioral data via digital smartphone devices to…
Continue Reading
What You Should Know:
– Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.
– Click’s expansion into cardiometabolic disease follows successful DTx development efforts in…
Continue Reading
Behavioral healthcare company Concert Health is partnering with WellSpan Health to allow the health system’s South Central Pennsylvania and Northern Maryland primary care providers to provide same-day behavioral health services to patients through the…
Continue Reading
What You Should Know:
– Concert Health, the leading collaborative care platform, today announced a partnership with WellSpan Health, an integrated delivery system serving South Central Pennsylvania and Northern Maryland, to expand access to same-day,…
Continue Reading
Table of Contents
Introduction
The Growing Need for Advanced Mental Health Monitoring
The Evolution of AI in Mental Health Research
Study Insights and Achievements
Challenges in Utilizing Social Media Data
The Future of AI in Mental Health Monitoring
FAQs
Conclusion
Introduction
In an era…
What You Should Know:
– Neuronetics, Inc. and Humana announce a significant step forward in adolescent mental healthcare. This collaboration offers new hope for young people struggling with major depressive disorder (MDD) by making transcranial…
Continue Reading
Background: Depressive disorder and type 2 diabetes mellitus (T2DM) are prevalent in primary care (PC). Pharmacological treatment, despite controversy, is commonly chosen due to resource limitations and difficulties in accessing face-to-face interventions. Depression significantly…
Continue Reading
When people think of patients being treated for depression, usually what comes to mind is someone sitting in weekly therapy sessions, and perhaps being prescribed a medication. But some clinicians and technologists see other…
Continue Reading
